SCA features state-of-the-art production facilities in both Arkansas and Connecticut.

Our 90,000 square foot production facility located in Windsor, CT opened in November 2017. This cutting edge facility features progressive design elements to facilitate quicker turnaround times and enhance our customers’ experience.

“We are very pleased that as we continue our geographical expansions, in both Arkansas and Connecticut, we can partner with AECD to solidify and expand the operations of our legacy operations,” said Milton Boyer CEO of SCA Pharma. “Ensuring that hospitals have all of the readily available sterile injectable pharmaceuticals they need to properly treat and care for patients is more critical today than ever before,” said Milton Boyer, CEO of SCA Pharma. “The demand for SCA products continues to increase, and we are committed to meeting that need safely, efficiently and reliably. Our new construction will position us to expand our capacity and make products even more accessible to hospitals.”